Harbour BioMed
和铂医药
elsewhere's corpus does not cover Harbour BioMed as a subject. The only mention in the bundle is a passing name-drop in a 2023 BlueRun Ventures piece about BioMap's partnerships, which lists Harbour BioMed (和铂医药) among several frontier biotech companies BioMap had collaborated with . There is no entity card, profile, or article about Harbour BioMed itself in the retrieved material.
AI-generated — may contain errors, please verify.
Harbour BioMedCompany
和铂医药
渲染中…
Mentioned in 4 articles
Coverage
Panning for Gold in the Light: Where AI Goes Next, Through the Eyes of a Tech Investor
Stand in the light, and stand there with more founders.
Deep Dive: China's "DeepSeek Moment" in Biotech | FreeS Fund Report
A Watershed Year for China's Innovative Drug Industry
$1 Billion! BioMap and Sanofi Partner to Develop AI Drug Discovery Models Based on Large Foundation Models | BlueRun Ventures Headlines
The First Commercial Partnership Based on Large Language Models in the Life Sciences Sector
The Hammer and the Dance: Where Healthcare Investment Goes Next Under COVID-19 | FreeS Fund
The unexpected arrival of COVID-19 turned out to be a shot in the arm for the healthcare industry.
